Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 6 (4), 382-427

Epidemiologic Evidence for Multiple Sclerosis as an Infection

Affiliations
Review

Epidemiologic Evidence for Multiple Sclerosis as an Infection

J F Kurtzke. Clin Microbiol Rev.

Erratum in

  • Clin Microbiol Rev 1994 Jan;7(1):141

Abstract

The worldwide distribution of multiple sclerosis (MS) can be described within three zones of frequency: high, medium, and low. The disease has a predilection for white races and for women. Migration studies show that changing residence changes MS risk. Studies of persons moving from high- to low-risk areas indicate that in the high-risk areas, MS is acquired by about age 15. Moves from low- to high-risk areas suggest that susceptibility is limited to persons between about ages 11 and 45. MS on the Faroe Islands has occurred as four successive epidemics beginning in 1943. The disease appears to have been introduced by British troops who occupied the islands for 5 years from 1940, and it has remained geographically localized within the Faroes for half a century. What was introduced must have been an infection, called the primary MS affection (PMSA), that was spread to and from successive cohorts of Faroese. In this concept, PMSA is a single widespread systemic infectious disease (perhaps asymptomatic) that only seldom leads to clinical neurologic MS. PMSA is also characterized by a need for prolonged exposure, limited age of susceptibility, and prolonged incubation. I believe that clinical MS is the rare late outcome of a specific, but unknown, infectious disease of adolescence and young adulthood and that this infection could well be caused by a thus-far-unidentified (retro)virus.

Similar articles

See all similar articles

Cited by 90 PubMed Central articles

See all "Cited by" articles

References

    1. Br Med J. 1978 Jul 29;2(6133):314-6 - PubMed
    1. Neurology. 1989 Jun;39(6):825-9 - PubMed
    1. Am J Hyg. 1953 May;57(3):380-96 - PubMed
    1. Ann Neurol. 1986 Sep;20(3):323-8 - PubMed
    1. Hum Immunol. 1986 Aug;16(4):364-74 - PubMed

Publication types

Feedback